Wafik Bardissi – CEO, Minapharm, Egypt
18.03.2016 / Pharmaboardroom
Ten years after his first interview with Focus Reports, Wafik Bardissi discusses Minapharm’s position as the leading biosimilar manufacturer in the Middle East.
Has Egypt taken steps to incentivize the development or registration of biosimilar products?
At present, more attention is required in Egypt to promote biosimilar development or encourage the registration of biosimilar products, and hence address the relevant funding structures needed. The proof is quite simple, as Minapharm is the only biotech player to have emerged in this part of the world during the last 15 years.